Article Information
History
- May 6, 2022.
Article Versions
- Version 1 (April 3, 2022 - 21:00).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Mackenzie A. Hamilton1,2,
- Ying Liu1,
- Andrew Calzavara1,
- Maria E. Sundaram1,3,
- Mohamed Djebli1,
- Dariya Darvin2,4,
- Stefan Baral5,
- Rafal Kustra6,
- Jeffrey C. Kwong1,6,7,8,9,10,‡ and
- Sharmistha Mishra2,11,12,13,‡,*
- 1ICES, Toronto, Canada
- 2MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada
- 3Centre for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, USA
- 4Department of Medicine, University of Toronto, Toronto, Canada
- 5Department of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, USA
- 6Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
- 7Public Health Ontario, Toronto, Canada
- 8Department of Family and Community Medicine, University of Toronto, Toronto, Canada
- 9University Health Network, Toronto, Canada
- 10Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Canada
- 11Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
- 12Department of Medicine, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada
- 13Institute of Medical Sciences, University of Toronto, Canada
- ↵*Corresponding author; email: sharmistha.mishra{at}utoronto.ca
↵‡ Authors contributed equally to this manuscript.
Posted May 06, 2022.
Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2
